The Oxford Vaccine Group has initiated a groundbreaking trial by vaccinating the first volunteer in a human study of a Lassa fever vaccine. This trial, supported...
The first volunteer has been vaccinated in a groundbreaking trial for a Lassa fever vaccine at the Oxford Vaccine Group. This trial, known as VITAL01, is...